Skip to main content

Detect Impairment with Real-time Measurements of Oxygen in the Lungs and Blood

Improve treatment and diagnostic decisions with fast, accurate, and non-invasive assessments of cardiorespiratory status using the MediPines AGM100®.

AGM-100-with-Mouthpiece-smaller
head

Fast

Results in under two minutes

head

Accurate

O2 and CO2  gas levels from the lungs sampled at rest

head

Painless

Non-Invasive: resting breath sampling with no needles 

New approach to established measures

background-video-mp

 

The AGM100 measures oxygenation, ventilation, and pulmonary gas exchange, all with one simple test. Vitally important clinical information now available at the point-of-care.

  • Gas Exchange

    Assessing respiratory impairment in patients is a critical aspect of clinical management. Traditionally, the Riley method (A-a gradient) has been the gold standard measure for gas exchange efficiency, but this approach...

    Read more


  • Clinical Accuracy

    Clinicians know that unlike other tests, the AGM100 provides accurate measurements of gas exchange impairment to differentiate healthy and sick patients...

    Read more


  • Operational Efficiency

    Patients in respiratory distress require immediate medical attention. The ability to quickly identify hypoxemia is crucial...

    Read more

One device, multiple measurements

agm100-devicefront

Clinicians using the AGM100 can compress the time to diagnosis and treatment decision throughout a patient's care continuum.  

  • Oxygenation
  • Ventilation
  • Gas Exchange Impairment
  • Diffusion limitations
  • Low inspired oxygen

Manage patients for positive health outcomes

Broad Applicability from hospitals to clinics 

ER/Critical Care

 

Pulmonology

 

Cardiology

 

Anesthesiology

  • Immediately identify respiratory impairment at the point of care
  • Support diagnosis and treatment decisions from chronic to acute cases
  • Confirm treatment effectiveness with a high degree of objectivity
  • Verify worsening/improving cardiorespiratory conditions 
  • Risk stratify patients before and after surgical procedure 

Brief overview of the MediPines AGM100

Industry Coverage

who logo

Innovative technologies are accelerating access to healthcare everywhere, we must ensure that they (innovative technologies) are readily available in all health facilities, fairly priced and quality-assured...

DR MARIÂNGELA SIMÃO
WHO Assistant Director General

 

la business journal logo

“The AGM100 is already playing a crucial role in respiratory assessment and treatment in a quickly growing number of hospitals across the nation."

LOS ANGELES BUSINESS JOURNAL

pictures-11

“These winners represent some of the most promising emerging medical device innovations in the diagnosis, treatment, and care of children affected..."

PAUL GRAND
CEO of MedTech Innovator

News

MediPines Wins Prestigious Pediatric Medical Device Competition Focused on COVID-19-Related Technologies

Published: Jul 24, 2020 ORANGE COUNTY, Calif., July 24, 2020 /PRNewswire/ -- MediPines, a respiratory medical device company, was selected a winner in the special COVID-19 edition ...
Sammy Lee

UCSD Distinguished Lecture Series

UCSD John B. West Distinguished Lecture Series, Sponsored by MediPines, to Feature Nobel Laureate Dr. Gregg L. Semenza August 02, 2023 11:57 AM Eastern Daylight Time MediPines, ...
Andrew Mcfadden

IdsMED Hong Kong Introduces MediPines AGM100 To A&E Doctors in a CME Event

idsMED partnered with the Hong Kong College of Emergency Medicine for a successful CME event with Steve Lee, CEO, and co-founder of MediPines as the keynote speaker. The event ...
Andrew Mcfadden

Medscape Interview Highlights MediPines AGM100’s 99% Accuracy for Emergency Room Oxygen Therapy Decisions in COVID-19 Patients

YORBA LINDA, Calif.–(BUSINESS WIRE)–In a video interview on “Hot Topics in Emergency Medicine” posted by Medscape, a group of emergency medicine experts and respiratory physiology ...
Sammy Lee

Medipines Featured in Los Angeles Business Journal

Innovative Technology Detects Respiratory Impairment Respiratory impairment detection has long been a diagnostic “blind spot,” with the traditional tools available causing ...
Sammy Lee

Physicians Use MediPines Non-Invasive Gas-Exchange Analyzer Technology to Assist with Differential Diagnosis for Pulmonary Embolism

YORBA LINDA, Calif., May 24, 2022–(BUSINESS WIRE)–An increasing number of physicians have been utilizing a unique gas exchange analyzer technology to enhance recognition and ...
Sammy Lee

MediPines Adds Three Global Thought Leaders to its Medical and Scientific Advisory Board

March 01, 2022 12:04 PM Eastern Standard Time YORBA LINDA, Calif.–(BUSINESS WIRE)–Orange County, California based MediPines Corporation, a market leader in the development of gas ...
Sammy Lee

World Health Organization Recognizes MediPines AGM100® in 2021 Compendium for Innovative Health Technologies

ORANGE COUNTY, Calif., Sept. 21, 2021 /CNW/ — The World Health Organization (WHO) has just featured MediPines AGM100®, pulmonary gas exchange analyzer as an innovative technology ...
Sammy Lee

MediPines AGM100® – Medical Design Excellence 2021 Award Winner

MediPines is pleased to announce that their AGM100® device has been awarded the prestigious Silver Award for Testing and Diagnostic Products in the 2021 Medical Design Excellence ...
Sammy Lee

MediPines AGM100® Gas Exchange Measurements Validated Against ABGs (Arterial Blood Gases)

Study Published in CHEST Validates MediPines AGM100® Non-invasive Pulmonary Gas Exchange Measurements with Arterial Blood Gases Under Hypoxic Conditions ORANGE COUNTY, Calif., May ...
Sammy Lee

MediPines Obtains International MDSAP ISO 13485 Medical Device Certification

ORANGE COUNTY, Calif., April 9, 2020 /PRNewswire/ — MediPines Corporation announces that it received the Medical Device Single Audit Program certification, MDSAP ISO 13485:2016 ...
Sammy Lee

MediPines Announces FDA Clearance of Breakthrough Respiratory Device, the MediPines Gas Exchange Monitor

ORANGE COUNTY, Calif., Jan. 29, 2019 /PRNewswire/ — MediPines Corporation announced today it has received FDA 510(k) market clearance on its new non-invasive medical device, the ...
Sammy Lee